A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael A Carducci, MD
Johns Hopkins Kimmel Cancer Center, Baltimore, MD
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
204 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Buenos Aires, Argentina
- Facility name not stated
Santa Rosa, Argentina
- Facility name not stated
Venado Tuerto, Argentina
- Facility name not stated
Camperdown, New South Wales, Australia
- Facility name not stated
Coffs Harbour, New South Wales, Australia
- Facility name not stated
Darlinghurst, New South Wales, Australia
- Facility name not stated
Tweed Heads, New South Wales, Australia
- Facility name not stated
Richmond, Victoria, Australia
- Facility name not stated
Subiaco, Western Australia, Australia
- Facility name not stated
Brussels, Belgium
- Facility name not stated
Ghent, Belgium
- Facility name not stated
Kortrijk, Belgium
- Facility name not stated
Liège, Belgium
- Facility name not stated
Botucatu, Sao Paulo, Brazil
- Facility name not stated
Cachoeiro de Itapemirim - ES, Brazil
- Facility name not stated
Curitiba, Parana, Brazil
- Facility name not stated
Florianópolis, Brazil
- Facility name not stated
Juiz de Fora, Minas Gerais, Brazil
- Facility name not stated
Mogi Das Cruzes, Sao Paulo, Brazil
- Facility name not stated
Natal, Rio Grande Do Norte, Brazil
- Facility name not stated
Passo Fundo, Brazil
- Facility name not stated
Porto Alegre, RS, Brazil
- Facility name not stated
Rio de Janeiro, Brazil
- Facility name not stated
Salvador/BA, Brazil
- Facility name not stated
São Paulo, Brazil
- Facility name not stated
Volta Redonda - RJ, Brazil
- Facility name not stated
Pleven, Bulgaria
- Facility name not stated
Plovdiv, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Varna, Bulgaria
- Facility name not stated
Kelowna, British Columbia, Canada
- Facility name not stated
Victoria, British Columbia, Canada
- Facility name not stated
Brantford, Ontario, Canada
- Facility name not stated
North York, Ontario, Canada
- Facility name not stated
Oakville, Ontario, Canada
- Facility name not stated
Santiago, Chile
- Facility name not stated
Temuco, Chile
- Facility name not stated
Viña del Mar, Chile
- Facility name not stated
Beijing, China
- Facility name not stated
Chengdu, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 28 Feb 2015
- Completion
- 31 Aug 2015
- Last update posted
- 21 Oct 2015
- Registered enrollment
- 1,245
- Registry id
- NCT01234311
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.